H.R. 4158 · 116th Congress
Combatting Unreasonable Rises and Excessively High Drug Prices Act
- Stage
- In committee
- Sponsor
- Chellie Pingree
- Introduced
- 2019-08-02
- Latest action
- 2019-08-05 · Referred to the Subcommittee on Health.
Summary
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.